In today’s ACT Brief, we explore how sites are taking the lead on AI adoption to strengthen feasibility and enrollment, why earlier cross-functional alignment is critical in data-driven trials, and ...
Jonathan Andrus, co-CEO of CRIO, discusses how governance across the data lifecycle, site-focused technology adoption, and scalable AI-enabled workflows will define operational readiness in 2026.
At SCOPE Summit 2026, site leaders shared how AI is transforming feasibility, patient identification, and enrollment strategies, enabling research sites to boost performance, strengthen sponsor ...
Andrus: Collaboration really needs to start earlier—during protocol development, not after the fact. Clinical operations, data management, and technology teams need to align on source workflows before ...
In today’s ACT Brief, we examine how fragmented data collection continues to challenge trial quality, how hybrid outsourcing ...
As clinical development grows more complex, sponsors are rethinking how outsourcing models, technology, and partnerships align to support both speed and sustainability. The shift toward hybrid models, ...
Steve Rosenberg, CEO of uMotif, explores the core challenges of clinical trial recruitment and retention, and discusses how digital tools empower sites and patients to build more effective, ...
Andrus: The biggest risk is fragmented, disconnected data collection across sites. If you think about a large phase 3 trial ...
In today’s ACT Brief, we examine how protocol-driven eSource is reshaping data capture at sites, how digital protocols and ...
Beyond sharing data, DQS aligns multiple data sources, including sponsors’ clinical trial management system data, public registries, and clinical trial databases, to provide a single, holistic, and ...
Insights from SCOPE 2026 highlight the industry’s shift toward connected, data-centric clinical trial ecosystems, where digital protocols, shared data, and renewed scientific rigor are driving more ...
Insights from SCOPE 2026 highlight the industry’s shift toward connected, data-centric clinical trial ecosystems, where digital protocols, shared data, and renewed scientific rigor are driving more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results